AML IP v. Aveda Corp.: Electronic Token Patent Suit Dismissed in 1 Day
AML IP, LLC filed suit against Aveda Corp. in the Western District of Texas asserting US7177838B1, a patent covering electronic token-based commerce transactions. The case was voluntarily dismissed without prejudice just one day after filing, before Aveda had answered or filed any motion, with each party bearing its own costs.
A one-day patent suit: tactical filing or immediate retreat?
On October 31, 2024, AML IP, LLC — a non-practicing entity represented by Ramey LLP — filed a patent infringement action against Aveda Corp. in the Western District of Texas before Judge Fred Biery. The asserted patent, US7177838B1, covers a method and apparatus for conducting electronic commerce transactions using electronic tokens, a foundational e-commerce technology area with broad commercial relevance.
Just one day later, on November 1, 2024, AML IP filed a notice of voluntary dismissal pursuant to Federal Rule of Civil Procedure 41(a)(1)(A)(i). Because Aveda had neither answered the complaint nor filed a motion for summary judgment, AML IP was entitled to dismiss as of right without court approval. The dismissal was expressly without prejudice as to the asserted patent, meaning the claims survive and AML IP retains the ability to refile against Aveda or assert the same patent against other defendants.
A one-day duration is highly atypical even for pre-answer voluntary dismissals and suggests the filing may have served a purpose other than pursuing full litigation — possibly initiating licensing discussions, testing jurisdiction, or addressing an administrative issue. The public record does not disclose whether any pre-dismissal communication or agreement occurred between the parties, and the cost-bearing arrangement — each side absorbs its own fees — is standard for Rule 41(a)(1) dismissals and does not signal a negotiated resolution.
Filing to Voluntary dismissal in 1 days
Case closed 1 day after filing — among the shortest patent litigation lifecycles on record
Voluntarily dismissed without prejudice: what the record reveals
Rule 41(a)(1)(A)(i): dismissal as of right, no court order needed
Federal Rule 41(a)(1)(A)(i) permits a plaintiff to dismiss an action without a court order by filing a notice before the opposing party serves an answer or a motion for summary judgment. AML IP invoked this right on day one. Because no judicial discretion is involved, this dismissal carries no ruling on the merits and creates no estoppel. The court record closes, but the legal dispute is not resolved.
No merits adjudicationDismissed without prejudice: the patent lives on
The notice expressly states the dismissal is without prejudice as to the asserted patent. This means AML IP may refile the same infringement claims against Aveda Corp. at any time within the applicable statute of limitations, or assert US7177838B1 against other parties. A without-prejudice dismissal under Rule 41(a)(1) does not bar future enforcement and should not be read as an admission of weakness in the patent’s validity or infringement theory.
Refiling risk remainsAveda exits without liability — but exposure is not extinguished
Aveda Corp. benefits from an immediate exit with no judgment, no injunction, and no fee award against it. However, the without-prejudice dismissal means Aveda has not secured a definitive resolution. The patent remains in force, and AML IP retains full enforcement rights. Aveda should treat this dismissal as a pause rather than a conclusion and consider whether a proactive freedom-to-operate or invalidity analysis is warranted.
No final resolution for defendantOne-day filings: a known NPE litigation tactic worth monitoring
Ultra-short patent cases filed and dismissed before any defendant response are consistent with several NPE strategies: initiating licensing pressure, testing forum selection, or resolving a pre-suit agreement quickly. The Western District of Texas remains a preferred venue for patent plaintiffs. Companies operating in the e-commerce and digital payments space with electronic token or transaction authentication functionality should monitor US7177838B1 and AML IP’s broader portfolio for re-assertion activity.
Monitor for re-assertionFull party and counsel information
| Role | Name | Type | Detail |
|---|---|---|---|
| Plaintiff | AML IP, LLC | Company | Non-practicing entity (NPE) — holder of US7177838B1 covering electronic token commerce methodsSearch in Eureka ↗ |
| Defendant | Aveda Corp. | Company | Aveda Corp. — professional beauty and personal care product companySearch in Eureka ↗ |
| Plaintiff counsel | Jeffrey Eugene Kubiak | Attorney | Counsel for AML IP, LLCSearch in Eureka ↗ |
| Plaintiff counsel | William P. Ramey , III | Attorney | Counsel for AML IP, LLCSearch in Eureka ↗ |
| Plaintiff law firm | Ramey LLP | Law Firm | Representing AML IP, LLCSearch in Eureka ↗ |
| Presiding judge | Judge Fred Biery | Judge | Texas Western District CourtSearch in Eureka ↗ |
Official order — verbatim text
The dismissal notice tracks the precise language of Rule 41(a)(1)(A)(i), confirming the procedural basis and the without-prejudice designation for the asserted patent. The explicit cost-bearing clause — each party absorbs its own fees — is standard for this mechanism and does not indicate a negotiated financial resolution. Critically, no merits finding was made on infringement, validity, or claim scope, leaving the patent’s enforceability entirely intact.
US7177838B1 — Electronic Token-Based Commerce Transaction Method
US7177838B1, filed under application number US09/553695, protects a method and apparatus for conducting electronic commerce transactions using electronic tokens. The patent sits within the foundational layer of digital payment infrastructure — covering the issuance, validation, and use of electronic tokens as a substitute or proxy for traditional payment credentials in online transaction flows. The application predates modern tokenisation standards, giving it a potentially broad priority date claim relative to widely deployed implementations.
From a competitive intelligence standpoint, this patent is strategically significant for any company operating tokenised payment, stored-value, or digital wallet functionality. The assertion against Aveda — a consumer-facing brand with e-commerce operations — suggests AML IP may be pursuing retail and direct-to-consumer platforms as targets. Fintech platforms, payment processors, and e-commerce enablers should assess whether their token-handling architectures fall within the claim scope of US7177838B1, particularly given the without-prejudice dismissal leaves enforcement fully open.
Should your team run an FTO analysis against US7177838B1?
Any company operating electronic token-based transaction functionality — whether in digital wallets, loyalty point redemption, stored-value cards, or tokenised checkout flows — should assess its exposure to US7177838B1. The without-prejudice dismissal in this case means AML IP has signalled intent without closing the door. E-commerce platforms, payment service providers, and SaaS commerce companies are the most likely next targets, particularly those with high transaction volumes and recognisable consumer brands.
PatSnap Eureka’s FTO Search Agent enables product and IP teams to map claim language from US7177838B1 against their specific technology stack, identify prior art that may challenge patent validity, and surface any related continuation or family patents held by AML IP. Running this analysis proactively — before a demand letter or complaint arrives — positions your team to respond strategically rather than reactively, and informs whether a design-around, licence negotiation, or IPR petition is the most commercially efficient path.
Run a freedom-to-operate analysis on US7177838B1 to assess your product’s exposure
Run FTO in Eureka →Similar electronic token and e-commerce patent cases in W.D. Texas
Explore related NPE-asserted electronic commerce and digital token patent cases filed in the Western District of Texas, including comparable Rule 41 dismissal patterns.
Related patent case — similar technology
Comparable case in the same technology domain. Patent holder and defendant reached resolution after proceedings.
SettledRelated infringement action — same court
Comparable Method and apparatus for conducting electronic commerce transactions using electronic tokens-adjacent infringement action. Patent enforcement dynamics analysed in depth.
Active · District CourtRelated invalidity challenge — appellate outcome
Combined invalidity and infringement action in the same technology space. Decided after substantive proceedings.
DecidedAML IP, LLC’s broader IP enforcement history
AML IP, LLC’s full litigation history covering prior enforcement, licensing activity, and inter partes review proceedings.
Portfolio viewWhat this case signals for the e-commerce patent IP landscape
A one-day filing-to-dismissal cycle in W.D. Texas rarely signals closure. For e-commerce technology companies, the risk profile here warrants attention.
Without-prejudice dismissals reset the clock — not the risk
AML IP retains full rights to refile against Aveda or any other party. Companies offering electronic transaction, token-based authentication, or digital payment features should audit their exposure to US7177838B1 now, not after a second filing arrives. A proactive invalidity or design-around analysis costs a fraction of litigation response.
W.D. Texas remains a high-velocity NPE venue — even 1-day cases matter
The Western District of Texas under Judge Biery continues to attract NPE filings. Even cases closed in a single day generate a public docket entry that can anchor future licensing demand letters. In-house teams should flag any W.D. Texas complaint in their technology space regardless of immediate resolution, as the filing itself has strategic value for the plaintiff.
US7177838B1 priority date and claim scope: what the prosecution history reveals
Filed under application no. US09/553695, this patent’s priority date and claim construction history may determine how broadly AML IP can assert electronic token methods against modern payment architectures. A claim mapping exercise against current tokenisation standards is advisable for any potential defendant.
Ramey LLP filing patterns: what serial NPE activity signals for your sector
Ramey LLP is a prolific NPE litigation firm with a documented history of high-volume patent assertion campaigns across technology sectors. Identifying co-pending suits involving US7177838B1 or related AML IP assets can reveal the full scope of the assertion campaign and inform a coordinated defence or licensing strategy.
AML v Aveda — key questions answered
A without-prejudice dismissal under Rule 41(a)(1)(A)(i) means no merits ruling was made and AML IP retains the right to refile the same infringement claims against Aveda or assert US7177838B1 against other defendants. The patent’s validity and enforceability are entirely unaffected by this dismissal.
The case was dismissed on day one because AML IP filed a voluntary dismissal notice before Aveda had answered or filed any motion. Under Rule 41(a)(1)(A)(i) this requires no court approval. The public record does not disclose the reason, but ultra-short filings by NPEs are consistent with pre-suit licensing activity, forum testing, or administrative corrections.
US7177838B1 covers a method and apparatus for conducting electronic commerce transactions using electronic tokens. Companies at risk include those operating tokenised checkout systems, digital wallets, stored-value platforms, loyalty redemption engines, or any system where an electronic token proxies a payment credential in an online transaction flow.
AML IP, LLC is a non-practicing entity that asserts patent rights rather than commercialising products. In this case it was represented by Ramey LLP, a firm known for high-volume NPE patent assertion activity. The filing pattern — W.D. Texas, pre-answer dismissal, without-prejudice terms — is consistent with a licensing pressure campaign targeting e-commerce operators.
Not necessarily. The clause stating each party bears its own costs, expenses, and attorneys’ fees is the default outcome for a Rule 41(a)(1)(A)(i) dismissal and does not confirm or deny any private agreement. Courts do not require disclosure of settlement terms under this mechanism, so the public record is silent on whether any financial arrangement was reached.
Don’t wait for the refile — run your e-commerce patent FTO now
AML IP’s without-prejudice dismissal keeps US7177838B1 fully live. PatSnap Eureka helps you map your token-based transaction architecture against active patent claims and monitor for new filings before a demand letter arrives.
PatSnap Eureka searches patents and litigation data to answer instantly.